Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor vs Clopidogrel for Coronary Microcirculation in Diabetics (PREDICT)
NCT02698618Phase 4Unknown
- Sponsor
- Fundación Interhospitalaria para la Investigación Cardiovascular
- Start
- Mar 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in type 2 diabetes mellitus (T2DM), ischemic heart disease (IHD), sponsored by Fundación Interhospitalaria para la Investigación Cardiovascular. Status: unknown.
02
Drugs
ticagrelor
03
Conditions
type 2 diabetes mellitus (T2DM)ischemic heart disease (IHD)
Beyond the preview
Go deeper on NCT02698618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02698618.